PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting - Seite 2

Kevin C. Zorn, MD, FACS, FRCSC
BPH Canada Prostate Surgery Institute
The study investigated the feasibility, safety and efficacy of same day discharge (SDD) after Aquablation specifically in an ASC.

Sunday, May 5, 2024
3:30 – 5:30 pm

• MP62-03: Aquablation Case Series of 812 Consecutive Men with LUTS due to BPH
  Shawn Marhamati, MD, MS
  Potomac Urology
  Three surgeons at a single center collected data on 812 consecutive men treated with Aquablation therapy. Routine procedural characteristics, adverse events, symptom scores and uroflow were collected.

Additional Activities

Company executives will be at PROCEPT booth #1429 during the AUA Saturday Afternoon Social on Saturday, 4-6 pm, to meet conference attendees.

PROCEPT BioRobotics is also a proud global supporter of the Urological Society for American Veterans (USAV) Forum which is being held on Sunday, May 5, 10 am – 2:30 pm at the Grand Hyatt Hotel in San Antonio. The meeting provides a forum for VA urologists and allied health GU providers to discuss all elements of concern to urological government health care. 

PROCEPT BioRobotics will sponsor additional satellite events during AUA at both the Henry B. Gonzalez Convention Center and off-site, including:

Event	Date	Time	Location
AUA Innovation Nexus	Thursday, May 2	8:00 AM – 6:00 PM	Henry B. Gonzalez Convention Center – Hemisfair C1
Indian American Urology Association Annual Meeting	Friday, May 3	8:00 AM – 2:00 PM	Henry B. Gonzalez Convention Center – Room 205
The Society of Benign Prostate Disease Annual Meeting	Monday, May 6	8:00 AM – 12:00 PM	Grand Hyatt San Antonio

For more information on Aquablation therapy and a full list of PROCEPT BioRobotics AUA activities, please visit www.procept-biorobotics.com/aua2024/.

About Aquablation Therapy
Aquablation therapy is the first and only ultrasound guided, robotic-assisted, heat-free waterjet for the treatment of BPH. The system’s real-time ultrasound imaging provides the surgeon with a multi-dimensional view of the prostate enabling personalized treatment planning tailored to each patient’s unique anatomy. The surgeon can specify which areas of the prostate to remove while preserving the anatomy that controls erectile function, ejaculatory function, and continence. Once the treatment plan is mapped by the surgeon, the predictable robotic-assisted execution enables prostate tissue to be removed in a precise, targeted, and controlled fashion.